The Custom Peptide Synthesis Services Market is estimated to be valued at USD 5.1 billion in 2025 and is projected to reach USD 11.1 billion by 2035, registering a compound annual growth rate (CAGR) of 8.1% over the forecast period.
| Metric | Value |
|---|---|
| Custom Peptide Synthesis Services Market Estimated Value in (2025 E) | USD 5.1 billion |
| Custom Peptide Synthesis Services Market Forecast Value in (2035 F) | USD 11.1 billion |
| Forecast CAGR (2025 to 2035) | 8.1% |
The Custom Peptide Synthesis Services market is experiencing notable growth due to the expanding applications of peptides across pharmaceutical, biotechnology, and life sciences research. Rising demand for personalized medicines, peptide-based therapeutics, and advanced drug discovery tools has positioned custom synthesis as a critical service offering. The increasing complexity of research requirements has accelerated the adoption of services that can deliver highly pure, sequence-specific peptides with shorter turnaround times.
Investments in automation and high-throughput technologies have further improved scalability and efficiency, ensuring consistent quality and reproducibility of synthesized peptides. Additionally, the surge in biologics research, vaccine development, and diagnostic innovations has created a strong pipeline that relies heavily on custom peptide solutions.
The future outlook for this market is supported by continuous advancements in synthesis platforms, a growing focus on oncology and immunotherapy research, and the rising use of peptides in preclinical and clinical trials As global pharmaceutical and biotech companies intensify their R&D expenditure, the market is expected to maintain strong momentum with significant opportunities for expansion.
The custom peptide synthesis services market is segmented by service type, end use, and geographic regions. By service type, custom peptide synthesis services market is divided into Solid Phase Custom Peptide Synthesis Services and Liquid Phase Custom Peptide Synthesis Services.
In terms of end use, custom peptide synthesis services market is classified into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization, and Academic And Research Institutes. Regionally, the custom peptide synthesis services industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The Solid Phase Custom Peptide Synthesis Services segment is projected to account for 60.00% of the Custom Peptide Synthesis Services market revenue in 2025, making it the dominant service type. This leading share is being attributed to the efficiency and reliability of solid phase methods in generating high-quality peptides with precise sequence control.
Solid phase synthesis allows for automation and parallel processing, which accelerates production timelines and ensures scalability for both research and commercial applications. The method’s capability to handle longer and more complex peptide chains with high purity has further reinforced its adoption in pharmaceutical and biotechnology research.
Continuous technological improvements have enhanced yield, reduced errors, and lowered costs, thereby making solid phase synthesis the preferred choice among service providers and end users alike The growing demand for peptides in drug discovery, immunology, and diagnostic assay development has also driven reliance on this method, as it supports flexible customization without compromising on reproducibility and performance standards.
The Pharmaceutical Companies end use segment is anticipated to hold 40.00% of the Custom Peptide Synthesis Services market revenue in 2025, establishing it as the largest end-user group. This prominence is being driven by the growing reliance of pharmaceutical firms on peptides for therapeutic development, including applications in oncology, metabolic disorders, infectious diseases, and cardiovascular conditions. Custom peptide synthesis services are enabling pharmaceutical companies to rapidly design and test novel sequences, accelerating preclinical and clinical pipelines.
The segment’s expansion has been reinforced by the rising demand for targeted therapies and biologics, where peptides offer high specificity and favorable safety profiles. Pharmaceutical firms are leveraging custom synthesis to address challenges in drug resistance, vaccine design, and precision medicine initiatives.
Additionally, collaborations between peptide synthesis providers and pharmaceutical companies are fostering innovation, enabling access to advanced technologies and expertise As R&D budgets continue to grow and the focus on personalized and peptide-based therapeutics intensifies, pharmaceutical companies are expected to sustain their leadership in driving demand for these services.
Custom peptide synthesis services is used to design enzymes, creating antibodies, testing drugs. Rather than synthesizing their own peptides scientist generally outsource this task to the Custom peptide synthesis services provider.
Custom peptide synthesis services provider synthesize the custom peptide according to the need of the researcher and deliver the final product to their laboratory. Custom peptide synthesis services provider can prepare two types of custom peptides viz. solid phase synthesis and liquid phase synthesis.
The most common solid phase custom peptide synthesis services include the C-terminus protected by solid resin. The option available of custom peptide synthesis services are phosphorylation, methylation, glycosylation, biotinylation, purification, and solubility testing, cyclization, or attachment to carrier proteins or dye.
A customized form of both monoclonal and polyclonal antibodies can be prepared by the custom peptide synthesis services. The cost-cutting by research organization and focus to prepare their own customized peptide may deter the growth of custom peptide synthesis services market.
| Country | CAGR |
|---|---|
| China | 10.9% |
| India | 10.1% |
| Germany | 9.3% |
| Brazil | 8.5% |
| USA | 7.7% |
| UK | 6.9% |
| Japan | 6.0% |
The Custom Peptide Synthesis Services Market is expected to register a CAGR of 8.1% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 10.9%, followed by India at 10.1%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates.
Japan posts the lowest CAGR at 6.0%, yet still underscores a broadly positive trajectory for the global Custom Peptide Synthesis Services Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 9.3%.
The USA Custom Peptide Synthesis Services Market is estimated to be valued at USD 1.7 billion in 2025 and is anticipated to reach a valuation of USD 1.7 billion by 2035. Sales are projected to rise at a CAGR of 0.0% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 259.3 million and USD 143.7 million respectively in 2025.
| Item | Value |
|---|---|
| Quantitative Units | USD 5.1 Billion |
| Service Type | Solid Phase Custom Peptide Synthesis Services and Liquid Phase Custom Peptide Synthesis Services |
| End Use | Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization, and Academic And Research Institutes |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
| Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
| Key Companies Profiled | Thermo Fisher Scientific, GenScript, Merck KGaA, Bachem, Bio-Synthesis Inc., Pepscan, ProteoGenix, JPT Peptide Technologies, PolyPeptide Group, and Creative Peptides |
How big is the custom peptide synthesis services market in 2025?
The global custom peptide synthesis services market is estimated to be valued at USD 5.1 billion in 2025.
What will be the size of custom peptide synthesis services market in 2035?
The market size for the custom peptide synthesis services market is projected to reach USD 11.1 billion by 2035.
How much will be the custom peptide synthesis services market growth between 2025 and 2035?
The custom peptide synthesis services market is expected to grow at a 8.1% CAGR between 2025 and 2035.
What are the key product types in the custom peptide synthesis services market?
The key product types in custom peptide synthesis services market are solid phase custom peptide synthesis services and liquid phase custom peptide synthesis services.
Which end use segment to contribute significant share in the custom peptide synthesis services market in 2025?
In terms of end use, pharmaceutical companies segment to command 40.0% share in the custom peptide synthesis services market in 2025.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Custom Peptide Synthesis Services Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
